Zobrazeno 1 - 10
of 185
pro vyhledávání: '"İrfan, Yavasoglu"'
Publikováno v:
Saudi Pharmaceutical Journal, Vol 26, Iss 7, Pp 943-946 (2018)
Aim: Anti-tumor necrosis factor-alpha (Anti-TNF-α) therapy has achieved an important position, are widely used for ankylosing spondylitis (AS) patients. TNF-α inhibition improves clinical outcomes and has differential effects on haematopoiesis. Inf
Externí odkaz:
https://doaj.org/article/ac0073a8d6db41b196206a588f8030b9
Autor:
Gokhan Sargin, Irfan Yavasoglu
Publikováno v:
Iraqi Journal of Hematology, Vol 8, Iss 1, Pp 45-47 (2019)
It has become important to be careful in terms of side effects with the increased lenalidomide use. The most commonly reported adverse events with the use of lenalidomide were hematologic toxicities and less frequently peripheral edema, infections, g
Externí odkaz:
https://doaj.org/article/0588f19195fd470db2e239694315e53c
Publikováno v:
São Paulo Medical Journal, Iss 0 (2018)
Externí odkaz:
https://doaj.org/article/a0286856ddbf403db2327958301bb0ed
Autor:
Elif Birtas Atesoglu, Zafer Gulbas, Ant Uzay, Muhit Ozcan, Fahir Ozkalemkas, Mehmet Sinan Dal, Hakan Kalyon, Olga Meltem Akay, Burak Deveci, Huseyin Bekoz, Omur Gokmen Sevindik, Tayfur Toptas, Fergun Yilmaz, Derya Koyun, Nihan Alkis, Inci Alacacioglu, Mehmet Sonmez, Irfan Yavasoglu, Anil Tombak, Ozgur Mehtap, Fatih Kurnaz, Orhan Kemal Yuce, Volkan Karakus, Mehmet Turgut, Derya Deniz Kurekci, Mesut Ayer, Muzaffer Keklik, Deram Buyuktas, Murat Ozbalak, Burhan Ferhanoglu
Glofitamab is a CD3xCD20 bi-specific antibody with two fragments directed to the CD20 antigen and a single CD3-binding fragment. Encouraging response and survival rates were recently reported in a pivotal phase II expansion trial conducted in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2497f4e81be510fd6626ab724fb52159
https://hdl.handle.net/11424/289907
https://hdl.handle.net/11424/289907
Autor:
Mevlüt Türe, Irfan Yavasoglu, Mustafa Celik, Altay Kandemir, Mehmet Hadi Yaşa, İsmail Taşkıran, Adil Coşkun, Sezgin Vatansever
Publikováno v:
Meandros Medical and Dental Journal. 22:274-281
Objective: Hypertriglyceridemia is the third most common cause of acute pancreatitis. Immediate triglyceride level lowering is beneficial in patients with severe hypertriglyceridemia [triglyceride (TG) >1,000 mg/dL]. This study aimed to compare the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4012afd637ace4c58c98ba8b6c0cc5c8
https://doi.org/10.4274/meandros.galenos.2021.54815
https://doi.org/10.4274/meandros.galenos.2021.54815
Autor:
Ali Zahit Bolaman, Irfan Yavasoglu, Sare İlknur Yavaşoglu, Nesim Akin, Celal Ulger, Esra Orenlili Yaylagul, Atakan Turgutkaya
Publikováno v:
International Blood Research & Reviews. :23-31
Introduction: FMS-Like Tyrosine Kinase Class 3 (FLT3) mutations harbor poor prognosis, high relapse, and decreased overall survival in acute myeloblastic leukemia (AML). This mutation is also known to be demonstrated in myelodysplastic syndrome (MDS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fae42c6305a4392b19aac9cbba624bb9
https://doi.org/10.9734/ibrr/2021/v13i130163
https://doi.org/10.9734/ibrr/2021/v13i130163
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 37, Iss 1, Pp 34-37 (2015)
Objective: CD20 expression was reported at different rates in patients with multiple myeloma. The importance of this B-cell antigen for plasma cells is still unknown. This study aimed to investigate CD20 expression of myeloma cells in bone marrow, an
Externí odkaz:
https://doaj.org/article/e63c7c0390104e23972b0dce4390faf0
Publikováno v:
Expert Review of Hematology. 14:1147-1153
Background The demographic characteristics, performance status, frequency of comorbidities and survival rate of patients with multiple myeloma (MM) show variability geographically and different risk scoring systems have been used to assess this popul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43d54dea354b1e5dadbd84223b3fce05
https://doi.org/10.1080/17474086.2021.1962279
https://doi.org/10.1080/17474086.2021.1962279
Publikováno v:
Journal of Hematopathology. 14:197-203
Malignancies accompanying multiple myeloma (MM) can be observed at diagnosis or during the course of the disease. Several trials have investigated the type, frequency, and effects of these malignancies on the overall survival of MM patients. Here, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b45cb8a782885d9f71ecf2631b773e3
https://doi.org/10.1007/s12308-021-00453-9
https://doi.org/10.1007/s12308-021-00453-9
Autor:
Mustafa Unubol, Engin Guney, Asli Demirkol, Irfan Yavasoglu, Aykut Soyder, Gökay Bozkurt, Zahit Bolaman
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 1, Pp 153-156 (2013)
Adrenal incidentaloma was detected in an 81-year-old male patient and a 37-year-old female patient who had been diagnosed with essential thrombocytosis. Each patient′s Janus Kinase 2 (JAK2) V617F mutation was positive, and they were evaluated as ha
Externí odkaz:
https://doaj.org/article/018fbf5e79984b3684f3ca0cd05b29cd